Testing firms are (again) back in favour
08/09/21 -"With the rise in Delta variant cases/risks in different parts of the world – especially in the US and Europe, testing firms are likely to witness re-emerging tailwinds. This has already begun ..."
Pages
74
Language
English
Published on
08/09/21
You may also be interested by these reports :
05/11/26
Siemens Healthineers’ Q4 profitability declined and was below market expectations. 2027 guidance also fell short of expectations. We will lower our ...
05/11/26
Tecan’s 3Q sales growth accelerated to 6.9% (LC), well above the 3.4% run rate of 1H26, with both segments contributing to the performance. ...
05/11/26
The strong 3Q print, combined with a positive FX effect, leads us to raise our 2026 sales estimate by c. 1.9%, which feeds through to our 2027 (c. ...
05/11/26
GN’s Q3 sales met market expectations, while profitability exceeded expectations, largely driven by tariff refunds. 2026 guidance was unchanged. ...